Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome

References

• Bunn PA Jr. The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol 1989;16:10–21.
   PubMed Web of Science ®Google Scholar
• Baruah H, Barry CG, Bierbach U. Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation. Curr Top Med Chem 2004;4:1537–1549.
   PubMed Web of Science ®Google Scholar
• Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, et al. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 1995;55:4293–4296.
   PubMed Web of Science ®Google Scholar
• Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y, et al. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum (II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res 1990;50:2549–2553.
   PubMed Web of Science ®Google Scholar
• Owatari S, Akune S, Komatsu M, Ikeda R, Firth SD, Che XF, et al. Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res 2007;67: 4860–4868.
   PubMed Web of Science ®Google Scholar
• Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 1990;62: 72–77.
   PubMed Web of Science ®Google Scholar
• Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 1991;51:3237–3242.
   PubMed Web of Science ®Google Scholar
• Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 2001;21:1129–1133.
   PubMed Web of Science ®Google Scholar
• Anestål K, Arnér ES. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem 2003;278:15966–15972.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Wada Y, Endo S, Soda M, El-Kabbani O, Hara A. Aldo-keto reductase 1B10 and its role in proliferation capacity of drug-resistant cancers. Front Pharmacol 2012;3:5.
   PubMed Web of Science ®Google Scholar
• Cao D, Fan ST, Chung SS. Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 1998;273:11429–11435.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, et al. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers’ non-small cell lung carcinomas. Clin Cancer Res 2005;11:1776–1785.
   PubMed Web of Science ®Google Scholar
• Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A. Identification and expression analysis of the aldo-keto reductase1–B10 gene in primary malignant liver tumours. J Hepatol 2010;52:220–227.
   PubMed Web of Science ®Google Scholar
• Soda M, Hu D, Endo S, Takemura M, Li J, Wada R, et al. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10. Eur J Med Chem 2012;48:321–329.
   PubMed Web of Science ®Google Scholar
• Yan R, Zu X, Ma J, Liu Z, Adeyanju M, Cao D. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. Int J Cancer 2007;121:2301–2306.
   PubMed Web of Science ®Google Scholar
• Crosas B, Hyndman DJ, Gallego O, Martras S, Parés X, Flynn TG, Farrés J. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J 2003; 373:973–979.
   PubMed Web of Science ®Google Scholar
• Endo S, Matsunaga T, Mamiya H, Ohta C, Soda M, Kitade Y, et al. Kinetic studies of AKR1B10, human aldose reductase-like protein: Endogenous substrates and inhibition by steroids. Arch Biochem Biophys 2009;487:1–9.
   PubMed Web of Science ®Google Scholar
• Shen Y, Zhong L, Johnson S, Cao D. Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds. Chem Biol Interact 2011;191:192–198.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Yamane Y, Iida K, Endo S, Banno Y, El-Kabbani O, Hara A. Involvement of the aldo-keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms. Anticancer Drugs 2011; 22:402–408.
   PubMed Web of Science ®Google Scholar
• Martin HJ, Maser E. Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Chem Biol Interact 2009;178:145–150.
   PubMed Web of Science ®Google Scholar
• Endo S, Matsunaga T, Ohta C, Soda M, Kanamori A, Kitade Y, et al. Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol. Chem Biol Interact 2011;191:261–268.
   PubMed Web of Science ®Google Scholar
• Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051–3064.
   PubMed Web of Science ®Google Scholar
• Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915–918.
   PubMed Web of Science ®Google Scholar
• Marletta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994;78:927–930.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Gath I, Schwarz P, Closs EI, Kleinert H. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol 1995;50: 1321–1332.
   PubMed Web of Science ®Google Scholar
• Derbyshire ER, Marletta MA. Structure and regulation of soluble guanylate cyclase. Annu Rev Biochem 2012;81:533–559.
   PubMed Web of Science ®Google Scholar
• Dawson TM, Dawson VL. Nitric oxide synthase: role as a transmitter/mediator in the brain and endocrine system. Annu Rev Med 1996;47:219–227.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Kotamraju S, Kalivendi SV, Dhanasekaran A, Joseph J, Kalyanaraman B. Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide. J Biol Chem 2004;279:28614–28624.
   PubMed Web of Science ®Google Scholar
• Kotamraju S, Matalon S, Matsunaga T, Shang T, Hickman-Davis JM, Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med 2006;40:1034–1044.
   PubMed Web of Science ®Google Scholar
• Aranda E, López-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A. Nitric oxide and cancer: the emerging role of S-nitrosylation. Curr Mol Med 2012;12:50–67.
   PubMed Web of Science ®Google Scholar
• Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and upregulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 1998;78:534–541.
   PubMed Web of Science ®Google Scholar
• Speranza L, De Lutiis MA, Shaik YB, Felaco M, Patruno A, Tetè S, et al. Localization and activity of iNOS in normal human lung tissue and lung cancer tissue. Int J Biol Markers 2007;22:226–231.
   PubMed Web of Science ®Google Scholar
• Srivastava AN, Gupta A, Srivastava S, Natu SM, Mittal B, Negi MP, Prasad R. Cisplatin combination chemotherapy induces oxidative stress in advance non-small cell lung cancer patients. Asian Pac J Cancer Prev 2010;11:465–471.
   PubMed Web of Science ®Google Scholar
• Chanvorachote P, Nimmannit U, Stehlik C, Wang L, Jiang BH, Ongpipatanakul B, Rojanasakul Y. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res 2006;66: 6353–6360.
   PubMed Web of Science ®Google Scholar
• Wongvaranon P, Pongrakhananon V, Chunhacha P, Chanvorachote P. Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. Anticancer Res 2013;33:5433–5444.
   PubMed Web of Science ®Google Scholar
• Kaur H, Lyras L, Jenner P, Halliwell B. Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue. J Neurochem 1998;70:2220–2223.
   PubMed Web of Science ®Google Scholar
• Hughes MN, Nicklin HG. The chemistry of pernitrites. Part I. Kinetics of decomposition of pernitrous acid. J Chem Soc A 1968;1968 450–452.
   Web of Science ®Google Scholar
• Esterbauer H, Weger W. Uber die Wirkungen von aldehyden auf gesunde und maligne zellen. 3. Mitt: Synthese von homologen 4-hydroxy-2-alkenalen. Monatsh Chem 1967;98: 1994–2000.
   Web of Science ®Google Scholar
• El-Kabbani O, Scammells PJ, Gosling J, Dhagat U, Endo S, Matsunaga T, et al. Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20α-hydroxysteroid dehydrogenase (AKR1C1). J Med Chem 2009;52:3259–3264.
   PubMed Web of Science ®Google Scholar
• Usui S, Matsunaga T, Ukai S, Kiho T. Growth suppressing activity for endothelial cells induced from macrophages by carboxymethylated curdlan. Biosci Biotechnol Biochem 1997;61:1924–1925.
   PubMed Web of Science ®Google Scholar
• Mohan S, Mohan N, Sprague EA. Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments. Am J Physiol 1997;273:C572–C578.
   Google Scholar
• Endo S, Matsunaga T, Kuragano T, Ohno S, Kitade Y, Tajima K, et al. Properties and tissue distribution of a novel aldo-keto reductase encoding in a rat gene (Akr1b10). Arch Biochem Biophys 2010;503:230–237.
   PubMed Web of Science ®Google Scholar
• Iino T, Tabata M, Takikawa S, Sawada H, Shintaku H, Ishikura S, Hara A. Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo-keto reductase AKR1 family members. Arch Biochem Biophys 2003;416: 180–187.
   PubMed Web of Science ®Google Scholar
• Shiraishi H, Matsuura K, Kume T, Hara A. Expression of mRNAs for dihydrodiol dehydrogenase isoforms in human tissues. Adv Exp Med Biol 1999;463:539–544.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Hosogai M, Arakaki M, Endo S, El-Kabbani O, Hara A. 9,10-Phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3. Biol Pharm Bull 2012;35: 1598–1602.
   PubMed Web of Science ®Google Scholar
• Sanson M, Augé N, Vindis C, Muller C, Bando Y, Thiers JC, et al. Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen- regulated protein 150 expression. Circ Res 2009;104: 328–336.
   PubMed Web of Science ®Google Scholar
• Takemura M, Endo S, Matsunaga T, Soda M, Zhao HT, El-Kabbani O, et al. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid. J Nat Prod 2011;74:1201–1206.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Hojo A, Yamane Y, Endo S, El-Kabbani O, Hara A. Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. Chem Biol Interact 2013;202: 234–242.
   PubMed Web of Science ®Google Scholar
• Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705–4708.
   PubMed Web of Science ®Google Scholar
• Song J, Liu D, Feng L, Zhang Z, Jia X, Xiao W. Protective Effect of Standardized Extract of Ginkgo biloba against Cisplatin-Induced Nephrotoxicity. Evid Based Complement Alternat Med 2013;2013:846126.
   PubMed Web of Science ®Google Scholar
• Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr, et al. Lipopolysaccharide induces Rac1- dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem 2001;276:30188–30198.
   PubMed Web of Science ®Google Scholar
• Das J, Ghosh J, Manna P, Sil PC. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via upregulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem Pharmacol 2011;81:891–909.
   PubMed Web of Science ®Google Scholar
• Li Q, Engelhardt JF. Interleukin-1beta induction of NFκB is partially regulated by H2O2-mediated activation of NFκB-inducing kinase. J Biol Chem 2006;281:1495–1505.
   PubMed Web of Science ®Google Scholar
• Babbar N, Casero RA Jr. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 2006;66: 11125–11130.
   PubMed Web of Science ®Google Scholar
• Liu H, Baliga R. Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 2005;16:1985–1992.
   PubMed Web of Science ®Google Scholar
• Coling DE, Ding D, Young R, Lis M, Stofko E, Blumenthal KM, Salvi RJ. Proteomic analysis of cisplatin-induced cochlear damage: methods and early changes in protein expression. Hear Res 2007;226:140–156.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang Z, Liu L, Chen L. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress- tolerant human lung cancer cells. Lung Cancer 2011;71: 291–297.
   PubMed Web of Science ®Google Scholar
• Hirst D, Robson T. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. Curr Pharm Des 2010;16:411–420.
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming H, Li Y, Cui W, Tong X, Norman H, Qi X, Wang S. Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function. Am J Physiol Renal Physiol 2013;305:F881–F890.
   PubMed Web of Science ®Google Scholar
• Rao CV. Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 2004;555:107–119.
   PubMed Web of Science ®Google Scholar
• Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001; 2:149–156.
   PubMed Web of Science ®Google Scholar
• Wong JC, Bathina M, Fiscus RR. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells. J Cell Biochem 2012;113:3587–3598.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Morikawa Y, Haga M, Endo S, Soda M, Yamamura K, et al. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through upregulation of aldo-keto reductase 1B10. Toxicol Appl Pharmacol 2014;278:180–189.
   PubMed Web of Science ®Google Scholar
• Antelmann H, Helmann JD. Thiol-based redox switches and gene regulation. Antioxid Redox Signal 2011;14:1049–1063.
   PubMed Web of Science ®Google Scholar
• Carballal S, Radi R, Kirk MC, Barnes S, Freeman BA, Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003; 42:9906–9914.
   PubMed Web of Science ®Google Scholar
• Alvarez B, Ferrer-Sueta G, Freeman BA, Radi R. Kinetics of peroxynitrite reaction with amino acids and human serum albumin. J Biol Chem 1999;274:842–848.
   PubMed Web of Science ®Google Scholar
• Ferrer-Sueta G, Radi R. Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem Biol 2009;4: 161–177.
   PubMed Web of Science ®Google Scholar